Results for:(157 found)
Jun 18, 2012 3:48PM on Top StocksBy InvestorPlace

The Supreme Court's decision on the massive health-care reform bill -- which could come at any time -- will surely create many winners and losers. Here’s a scorecard.

Jun 18, 2012 10:09AM on Top StocksBy Gene Marcial

The world's largest drugmaker plans to spin off its animal health unit, which should boost its stock.

Tags: PFE
Jun 7, 2012 12:28PM on Top StocksBy MSN Money Partner

The market gives back some of its earlier gains after Bernanke's testimony.

May 1, 2012 12:18PM on Top StocksBy MSN Money Partner

Positive manufacturing reports in the US and China boost stocks.

Apr 30, 2012 3:49PM on Top StocksBy Jim J. Jubak

Novo Nordisk commands a high price on the market -- and finds itself up against high expectations as well.

Apr 24, 2012 2:56PM on Top StocksBy Jim J. Jubak

The company has been losing market share in the country since 2005. Its latest acquisition changes that.

Tags: PFE
Apr 23, 2012 1:28PM on Top StocksBy MSN Money Partner

Political uncertainty in Europe and allegations of bribery at Wal-Mart kick the week off on a sour note.

Apr 18, 2012 1:29PM on Top StocksBy Trefis

The FDA adds warning about sexual side effects to Propecia, a drug used to treat baldness.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More